Call of Duty at the Frontier of Research: Normative Epistemology for High-Risk/High-Gain Studies of Deep Brain Stimulation.
暂无分享,去创建一个
[1] M. McCormick. Ethics of Belief , 2020, International Encyclopedia of Ethics.
[2] S. Müller,et al. Opening the debate on deep brain stimulation for Alzheimer disease – a critical evaluation of rationale, shortcomings, and ethical justification , 2018, BMC Medical Ethics.
[3] S. John. Epistemic trust and the ethics of science communication: against transparency, openness, sincerity and honesty , 2018 .
[4] T. Insel. Join the disruptors of health science , 2017, Nature.
[5] M. Johansson,et al. Challenges to Informed Consent in First-In-Human Trials Involving Novel Treatments: A Case Study of Parkinson’s Disease , 2017, Journal of Parkinson's disease.
[6] S. Mueller,et al. P 137 An ethical perspective on deep brain stimulation as an investigational treatment for Alzheimer’s disease , 2017, Clinical Neurophysiology.
[7] Gerd Gigerenzer,et al. Can facts trump unconditional trust? Evidence-based information halves the influence of physicians’ non-evidence-based cancer screening recommendations , 2017, PloS one.
[8] F. Gilbert,et al. Currents of memory: recent progress, translational challenges, and ethical considerations in fornix deep brain stimulation trials for Alzheimer's disease , 2017, Neurobiology of Aging.
[9] Sanford C. Goldberg. Should have known , 2017, Synthese.
[10] J. Fins. In Reply: Commentary: Deep Brain Stimulation as Clinical Innovation: An Ethical and Organizational Framework to Sustain Deliberations About Psychiatric Deep Brain Stimulation. , 2017, Neurosurgery.
[11] Jeannie-Marie S. Leoutsakos,et al. A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease , 2016, Journal of Alzheimer's disease : JAD.
[12] Brian A. Nosek,et al. How open science helps researchers succeed , 2016, eLife.
[13] E. Racine,et al. Deep Brain Stimulation as Clinical Innovation: An Ethical and Organizational Framework to Sustain Deliberations About Psychiatric Deep Brain Stimulation. , 2016, Neurosurgery.
[14] N. Eyal. How to keep high-risk studies ethical: classifying candidate solutions , 2016, Journal of Medical Ethics.
[15] Genserik Reniers,et al. On the assessment of uncertainty in risk diagrams , 2016 .
[16] Jelte M. Wicherts,et al. Peer Review Quality and Transparency of the Peer-Review Process in Open Access and Subscription Journals , 2016, PloS one.
[17] Valerie C. Henderson,et al. Assessing risk/benefit for trials using preclinical evidence: a proposal , 2015, Journal of Medical Ethics.
[18] S. Goodman,et al. Meta-research: Evaluation and Improvement of Research Methods and Practices , 2015, PLoS biology.
[19] Brian A. Nosek,et al. Promoting an open research culture , 2015, Science.
[20] J. Kimmelman,et al. The structure of clinical translation: efficiency, information, and ethics. , 2015, The Hastings Center report.
[21] J. Cummings,et al. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.
[22] K. Zilles,et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia , 2014, Molecular Psychiatry.
[23] Ulrich Dirnagl,et al. Distinguishing between Exploratory and Confirmatory Preclinical Research Will Improve Translation , 2014, PLoS biology.
[24] J. Kimmelman,et al. A theoretical framework for early human studies: uncertainty, intervention ensembles, and boundaries , 2012, Trials.
[25] D. Howells,et al. Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.
[26] Iveta Simera,et al. Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research , 2008, BMC medicine.
[27] C. Grady,et al. What makes clinical research ethical? , 2000, JAMA.
[28] M. Knopp,et al. Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.
[29] C. Grady,et al. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. , 2003, IRB.